StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
20
This month
2
This week
1
This year
3
Publishing Date
2024 - 04 - 15
1
2024 - 04 - 11
1
2024 - 03 - 15
1
2023 - 05 - 03
1
2022 - 11 - 15
1
2022 - 10 - 20
1
2022 - 05 - 18
1
2022 - 04 - 19
1
2022 - 03 - 02
1
2022 - 01 - 04
1
2021 - 12 - 02
1
2021 - 09 - 09
1
2021 - 08 - 23
1
2021 - 08 - 18
1
2021 - 08 - 13
1
2021 - 04 - 26
1
2021 - 04 - 13
1
2021 - 02 - 11
1
2021 - 01 - 07
1
2020 - 12 - 08
1
Sector
Health technology
20
Tags
Active
1
Agreement
3
Alliances
3
Application
4
Approval
1
Awards
2
Cancer
1
Ceo
3
Clearance
2
Clinical-trials-phase-ii
3
Clinical-trials-phase-iii
3
Commercialization
1
Conference
9
Contract
1
Covid
3
Covid-19
2
Designation
4
Disease
8
Distribution
2
Drug
8
Earnings
4
Ebola
2
Events
5
Fda
14
Financial
6
Financial results
3
For
2
Funding
3
Global
2
Grant
4
Granted
2
Grants
3
Infection
2
Marburg
4
Market
2
Meeting
9
N/a
51
Partnership
2
Patent
4
Pharm-country
20
Phase 2
2
Phase 3
2
Platform
2
Positive
5
Presentation
3
Product-news
2
Proposal
2
Psoriasis
6
Publication
2
Regulatory
2
Research
12
Results
15
Review
2
Sgx302
4
Study
8
T-cell
15
Technology
3
Treatment
19
Trial
6
Vaccine
12
Entities
Soligenix, inc.
20
Symbols
AMRN
14
AMRX
26
ANVS
16
APDN
36
ATNM
19
AVXL
12
BDX
20
BHVN
16
BMY
67
CERT
12
CTSO
12
CTXR
16
DGX
21
ECOR
19
FNCTF
22
HOTH
19
HSIC
14
ICPT
12
IMUX
15
INAB
17
INSM
21
ISEE
14
JNJ
70
KRMD
18
KRYS
12
LEGN
19
LLY
15
LUCD
17
MRK
47
MRNS
23
MS
15
NAOV
14
NRXP
21
ORMP
15
PAVM
17
PDSB
20
PFE
33
PTCT
14
PTPI
16
RCKT
15
REGN
13
RLYB
13
SCYX
12
SDGR
22
SEEL
18
SLS
16
SNGX
20
SNY
54
SNYNF
42
SONN
14
STIM
16
TEVA
19
TEVJF
18
TGTX
14
TNXP
31
TRVI
12
TRVN
16
URGN
25
VRPX
17
YMAB
22
Exchanges
Nasdaq
20
Crawled Date
2024 - 04 - 15
1
2024 - 04 - 11
1
2024 - 03 - 15
1
2023 - 05 - 03
1
2022 - 11 - 15
1
2022 - 10 - 20
1
2022 - 05 - 18
1
2022 - 04 - 19
1
2022 - 03 - 02
1
2022 - 01 - 04
1
2021 - 12 - 02
1
2021 - 09 - 09
1
2021 - 08 - 23
1
2021 - 08 - 18
1
2021 - 08 - 13
1
2021 - 04 - 26
1
2021 - 04 - 13
1
2021 - 02 - 11
1
2021 - 01 - 07
1
2020 - 12 - 08
1
Crawled Time
12:00
6
13:00
7
13:20
1
13:30
1
14:00
1
16:01
1
19:00
1
20:00
1
23:00
1
Source
www.biospace.com
20
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Pharm-country
symbols :
Sngx
save search
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection
Published:
2024-04-15
(Crawled : 13:00)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
11.37%
|
O:
75.34%
H:
37.73%
C:
-30.58%
fda
drug
marburg
infection
designation
for
grants
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Sudan Ebolavirus Infection
Published:
2024-04-11
(Crawled : 20:00)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
-7.13%
|
O:
3.67%
H:
0.46%
C:
-19.02%
fda
drug
infection
designation
for
grants
Soligenix Announces Recent Accomplishments and Year End 2023 Financial Results
Published:
2024-03-15
(Crawled : 13:00)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
-32.47%
|
O:
0.5%
H:
7.98%
C:
-3.13%
year
financial
results
Soligenix Announces Appointment of Timothy R. Coté, M.D. to its Board of Directors
Published:
2023-05-03
(Crawled : 13:00)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
-73.13%
|
O:
1.24%
H:
3.4%
C:
-12.35%
Soligenix to Receive $1.2 M in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program
Published:
2022-11-15
(Crawled : 13:20)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
-95.96%
|
O:
0.0%
H:
2.66%
C:
-6.8%
transfer
program
technology
funding
Soligenix Announces Adjournment of Annual Meeting and Information for Reconvened Meeting
Published:
2022-10-20
(Crawled : 13:00)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
-95.6%
|
O:
2.81%
H:
0.0%
C:
-1.48%
meeting
Soligenix to Present at the H.C. Wainwright Global Investment Conference
Published:
2022-05-18
(Crawled : 13:00)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
-5.54%
|
O:
3.25%
H:
10.64%
C:
-5.89%
conference
Soligenix Receives $1.4M in Non-Dilutive Government Funding
Published:
2022-04-19
(Crawled : 12:00)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
-38.55%
|
O:
0.47%
H:
0.04%
C:
-1.22%
funding
Soligenix to Present at the Q1 Virtual Investor Summit
Published:
2022-03-02
(Crawled : 13:30)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
-36.92%
|
O:
-0.25%
H:
4.82%
C:
-2.63%
Dusquetide Demonstrates Positive Anti-tumor Efficacy in Multiple Nonclinical Animal Studies
Published:
2022-01-04
(Crawled : 23:00)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
-37.41%
|
O:
12.47%
H:
17.77%
C:
-5.81%
positive
Soligenix Announces Successful Protection using a Bivalent Thermostabilized Filovirus Vaccine
Published:
2021-12-02
(Crawled : 13:00)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
-50.57%
|
O:
-4.6%
H:
1.22%
C:
-6.0%
vaccine
FDA Grants Soligenix Orphan Drug Designation for the Treatment of T-cell Lymphoma
Published:
2021-09-09
(Crawled : 12:00)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
-59.05%
|
O:
12.38%
H:
4.24%
C:
-1.69%
treatment
fda
drug
t-cell
granted
grant
designation
Soligenix Announces Publication Demonstrating Successful Formulation and Heat Stabilization of Filovirus Vaccine Platform for Ebola and Marburg Virus Diseases
Published:
2021-08-23
(Crawled : 12:00)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
-50.43%
|
O:
7.22%
H:
1.4%
C:
0.49%
disease
vaccine
marburg
Soligenix Announces Positive Preclinical Data with Multiple Heat Stable Filovirus Vaccine Candidates
Published:
2021-08-18
(Crawled : 14:00)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
-52.06%
|
O:
15.94%
H:
6.73%
C:
-7.79%
positive
vaccine
preclinical
pre-clinical
Soligenix Announces Recent Accomplishments And Second Quarter 2021 Financial Results
Published:
2021-08-13
(Crawled : 12:00)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
-54.48%
|
O:
-0.48%
H:
0.0%
C:
0.0%
financial results
results
HyBryte™ Expanded Efficacy and Safety Data Presented at the American Academy of Dermatology Meeting
Published:
2021-04-26
(Crawled : 12:00)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
-69.72%
|
O:
1.41%
H:
9.72%
C:
9.72%
Soligenix Announces Presentations at Prominent Scientific Conferences
Published:
2021-04-13
(Crawled : 12:00)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
-69.93%
|
O:
1.4%
H:
0.69%
C:
-0.69%
presentation
conference
Soligenix to Present at the 2021 BIO CEO & Investor Digital Conference
Published:
2021-02-11
(Crawled : 13:00)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
-75.5%
|
O:
6.55%
H:
12.3%
C:
11.23%
ceo
leo
Soligenix Announces Strategic Partnership with Daavlin for Supply and Distribution of the SGX301 Companion Light Device in the Treatment of Cutaneous T-Cell Lymphoma
Published:
2021-01-07
(Crawled : 19:00)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
-67.18%
|
O:
9.92%
H:
5.56%
C:
-0.69%
partnership
distribution
t-cell
treatment
Soligenix Demonstrates Extended Protection with its RiVax® Ricin Toxin Vaccine
Published:
2020-12-08
(Crawled : 16:01)
- biospace.com/
SNGX
|
$0.4233
-2.76%
-2.83%
1M
|
Health Technology
|
-81.78%
|
O:
5.08%
H:
0.0%
C:
-6.85%
vaccine
Gainers vs Losers
67%
33%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.